Early research (Phase 1)Study completedNCT02423525What this trial is testingSafety Study of Afatinib for Brain CancerWho this might be right forBrain Cancer Santosh Kesari 24
Not applicableActive Not RecruitingNCT00935090What this trial is testing3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Active Not RecruitingNCT06048718What this trial is testingT-DXd Therapy for HER2-low Breast Cancer Patients With Brain MetastasesWho this might be right forBreast CancerMetastatic Breast Cancer MedSIR 28
Not applicableStudy completedNCT04705610What this trial is testingSocial Cognition in Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculographyWho this might be right forMultiple Sclerosis (MS)Multiple Sclerosis (MS) Relapsing RemittingMultiple Sclerosis (MS) Primary Progressive+4 more Association de Recherche Bibliographique pour les Neurosciences 76
Not applicableEnded earlyNCT00952185What this trial is testingInfluenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy VolunteersWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+7 more City of Hope Medical Center 9
Not applicableEnded earlyNCT00899951What this trial is testingStudying Fentanyl in Patients With CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2
Testing effectiveness (Phase 2)Looking for participantsNCT02896335What this trial is testingPalbociclib and Pembrolizumab In Central Nervous System MetastasesWho this might be right forMetastatic Malignant Neoplasm to BrainRecurrent Brain MetastasesProgressive Brain Metastases Massachusetts General Hospital 45
Testing effectiveness (Phase 2)Looking for participantsNCT07505173What this trial is testingHippocampus-Protective Radiotherapy Combined With Osimertinib for Symptomatic Brain Metastases in EGFR-Mutated Lung CancerWho this might be right forNaive Advanced Non-small Cell Lung Cancer With EGFR-sensitive Mutations (EGFR Exon 19 Deletion and Exon 21 L858R Mutation) and Symptomatic Brain Metastases Tianjin Medical University Cancer Institute and Hospital 74
Not applicableWithdrawnNCT00900120What this trial is testingCollecting and Storing Blood Samples From Patients With CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more University of Medicine and Dentistry of New Jersey
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT01056471What this trial is testingAutologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple SclerosisWho this might be right forAutoimmune DiseasesImmune System DiseasesDemyelinating Diseases+3 more Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud 30
Testing effectiveness (Phase 2)Study completedNCT01684761What this trial is testingStudy of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple SclerosisWho this might be right forAutoimmune Diseases of the Nervous SystemMultiple SclerosisSecondary Progressive Multiple Sclerosis+2 more Opexa Therapeutics, Inc. 183
Testing effectiveness (Phase 2)Study completedNCT00110045What this trial is testingCaspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell TransplantWho this might be right forCancer European Organisation for Research and Treatment of Cancer - EORTC 171
Testing effectiveness (Phase 2)Looking for participantsNCT07383649What this trial is testingTrial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV InfectionWho this might be right forBrain Cancer MetastaticCMV Viremia The Methodist Hospital Research Institute 28
Testing effectiveness (Phase 2)Study completedNCT00257855What this trial is testingA Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple SclerosisWho this might be right forSecondary Progressive Multiple Sclerosis University College London Hospitals 120
Testing effectiveness (Phase 2)Ended earlyNCT02166658What this trial is testingCabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet)Who this might be right forBreast CancerLung CancerRecurrent Brain Metastases+1 more AIO-Studien-gGmbH 8
Testing effectiveness (Phase 2)Study completedNCT01910259What this trial is testingMS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation TrialWho this might be right forSecondary Progressive Multiple Sclerosis University College, London 445
Early research (Phase 1)Temporarily pausedNCT06677710What this trial is testingIDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple SclerosisWho this might be right forMultiple SclerosisPrimary Progressive Multiple Sclerosis (PPMS)Secondary Progressive Multiple Sclerosis (SPMS)+8 more Indapta Therapeutics, INC. 34
Testing effectiveness (Phase 2)WithdrawnNCT03803761What this trial is testingA New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Malignant Neoplasm in the Brain+1 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT00227656What this trial is testingCapecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast CancerWho this might be right forBreast CancerMetastatic Cancer M.D. Anderson Cancer Center 2